Literature DB >> 21175277

Are glucose readings sufficient to adjust insulin dosage?

Eran Bashan1, William H Herman, Israel Hodish.   

Abstract

AIMS/HYPOTHESIS: insulin therapy is effective predominantly when dosage is frequently adjusted. However, a controversy surrounds the pertinent clinical parameters required to make effective and safe frequent dosage adjustments. We hypothesize that glucose readings are sufficient to adjust insulin dosage provided that dosage is adjusted every 1-4 weeks.
METHODS: to test the hypothesis, we generated several algorithms implemented in software to process glucose readings and recommend insulin dosage adjustments. A post hoc analysis was made on 630 log sheets (2,520 insulin dosage adjustments) from 26 older adults with suboptimally controlled type 2 diabetes. The subjects were followed for a year and treated with intensive insulin therapy that was titrated every 1-4 weeks by a trained study team. More than 88% of subjects attained the treatment goal (hemoglobin A1c <7%) without excessive hypoglycemia. Glucose readings from each log sheet were used as an input to the software, and its recommendations for insulin dosage adjustments were compared to the original ones made by the study team. While the study team could have been exposed to multiple clinical parameters, the software relied solely on glucose readings.
RESULTS: the software recommendations for dosage adjustments were clinically equivalent to the original study team's recommendations in more than 95% of the cases, unrelated to patients' insulin sensitivity. The remaining 4.4% (n = 111) were thoroughly examined, yet we did not find any recommendations suggested by the software to be unsafe or unreasonable. CONCLUSIONS/
INTERPRETATION: glucose readings are sufficient to effectively adjust insulin dosage provided that adjustments are made every 1-4 weeks. Therefore, dedicated software can help adjusting insulin dosage between clinic visits.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21175277     DOI: 10.1089/dia.2010.0112

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  7 in total

1.  Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial.

Authors:  Richard M Bergenstal; Mary Johnson; Rebecca Passi; Anuj Bhargava; Natalie Young; Davida F Kruger; Eran Bashan; Stanley G Bisgaier; Deanna J Marriott Isaman; Israel Hodish
Journal:  Lancet       Date:  2019-02-23       Impact factor: 79.321

2.  Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses.

Authors:  John E Schneider; Anjani Parikh; Ivana Stojanovic
Journal:  J Health Econ Outcomes Res       Date:  2018-02-20

3.  A novel approach to optimise glycaemic control in insulin users.

Authors:  Eran Bashan; Roy Harper; Yixi Bi; Israel Hodish
Journal:  BMJ Case Rep       Date:  2015-07-31

4.  Can a tool that automates insulin titration be a key to diabetes management?

Authors:  Richard M Bergenstal; Eran Bashan; Margaret McShane; Mary Johnson; Israel Hodish
Journal:  Diabetes Technol Ther       Date:  2012-05-08       Impact factor: 6.118

5.  A Minority of Patients with Type 1 Diabetes Routinely Downloads and Retrospectively Reviews Device Data.

Authors:  Jenise C Wong; Aaron B Neinstein; Matthew Spindler; Saleh Adi
Journal:  Diabetes Technol Ther       Date:  2015-07-02       Impact factor: 6.118

6.  Insulin therapy for type 2 diabetes - are we there yet? The d-Nav® story.

Authors:  I Hodish
Journal:  Clin Diabetes Endocrinol       Date:  2018-04-10

7.  Comparison of Insulin Dose Adjustments by Primary Care Physicians and Endocrinologists.

Authors:  Mayer B Davidson; Petra Duran; S Joshua Davidson; Martin Lee
Journal:  Clin Diabetes       Date:  2018-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.